Stay updated on AbbVie Press Releases
Sign up to get notified when there's something new on the AbbVie Press Releases page.

Latest updates to the AbbVie Press Releases page
- Check6 days agoChange DetectedThe News Center feed is refreshed with new June 2026 announcements and related social updates, and older Q1 2026 items are removed, resulting in a more current main news page.SummaryDifference12%

- Check13 days agoChange DetectedNew May 27 and May 22 press releases were added, including the U.S. FDA approval of DECNUPAZ and CHMP opinion for MAVIRET, plus new ASCO 2026 data; several older posts were removed from the All News listing (e.g., TrenibotulinumtoxinE update, manufacturing campus announcement, Q1 2026 results).SummaryDifference11%

- Check20 days agoChange DetectedNew May 21, 2026 entry announcing Allergan Aesthetics' CHMP opinion for Boey has been added. It also includes a note about upcoming ASCP 2026 activities and related poster presentations on psychiatric disorder research.SummaryDifference7%

- Check27 days agoChange DetectedThe Latest news list's relative time markers were updated: '15 days ago' was added, and '2 days ago' and '8 days ago' were removed.SummaryDifference0.7%

- Check34 days agoChange DetectedNew entries for May 6, 2026 and May 5, 2026 were added to the Latest News section, highlighting AbbVie’s Bank of America conference presentation and DDW 2026 data. Older or related posts (e.g., Alopecia Areata and 340B-related items) were removed.SummaryDifference10%

- Check41 days agoChange DetectedNew entries appear in Latest news for April 30–28, 2026, including Allergan Aesthetics' philanthropic effort and AbbVie’s first‑quarter financial results, plus an FDA submission for Upadacitinib; associated social posts and callouts are added, while older news items are removed from the listing to reflect current coverage.SummaryDifference11%

Stay in the know with updates to AbbVie Press Releases
Enter your email address, and we'll notify you when there's something new on the AbbVie Press Releases page.